A Study of Erdafitinib Versus Investigator Choice of Intravesical Chemotherapy in Participants Who Received Bacillus Calmette-Guérin (BCG) and Recurred With High Risk Non-Muscle-Invasive Bladder Cancer (NMIBC)
Janssen Research & Development, LLC
Janssen Research & Development, LLC
University of Florida
UroGen Pharma Ltd.
Radiation Therapy Oncology Group
UroGen Pharma Ltd.
UroGen Pharma Ltd.
Corewell Health West
Mayo Clinic
Viralytics
Halozyme Therapeutics
UroGen Pharma Ltd.
Memorial Sloan Kettering Cancer Center
Duke University